Venture Capital

The state of investment: 'biotech is up'

Dispatches from BIO 2016

The state of investment: 'biotech is up'

By Melissa Fassbender

The biopharmaceutical industry broke several records in 2015 – but to continue the trend will require a sustained investment from multiple stakeholders.

Architects' plans for the Nottingham, UK facility

$47m innovation facility built in Nottingham, UK

By Fiona BARRY

The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture capital fund which will invest in the SME tenants.

PCI’s CEO Bill Mitchell told he plans to have the two firms continue to operate as distinct companies

Packaging firm PCI buys Welsh CDMO for $215m

By Fiona BARRY

Packaging Coordinators Inc (PCI) has announced its acquisition of Welsh contract development and manufacturing organisation (CDMO) Penn Pharmaceutical Services in a £127m ($215m) deal.

Private equity to buy SeraCare

Private equity to buy SeraCare

By Nick Taylor

SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...


Follow us


View more


Featured Suppliers